MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lunai Bioworks Inc. - Common Stock (NQ:RENB)

1.420 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.420
Bid (Size) 1.530 (5)
Ask (Size) 1.540 (48)
Prev. Close 1.420
Today's Range 1.420 - 1.420
52wk Range 0.1214 - 1.420
Shares Outstanding 24,187,356
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
These stocks are moving in today's after hours session ↗
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million. 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+644.6%
+644.6%
1 Year
+84.9%
+84.9%

More News

Read More
News headline image
Gapping stocks in Thursday's session ↗
Via Chartmill
News headline image
Top movers in Thursday's pre-market session ↗
Via Chartmill
News headline image
Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Top movers in Wednesday's after hours session ↗
Via Chartmill
News headline image
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
Via ACCESS Newswire
News headline image
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women’s Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
Via ACCESS Newswire
News headline image
Top 3 Health Care Stocks You'll Regret Missing In Q3 ↗
Via Benzinga
News headline image
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
Via ACCESS Newswire
News headline image
Lunai Bioworks Strengthens European Strategy Through Restructuring
Via ACCESS Newswire
News headline image
Lunai Bioworks Inc. Retains American Defense International
Via ACCESS Newswire
News headline image
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics
Via ACCESS Newswire
News headline image
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks
Via ACCESS Newswire
News headline image
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector
Via ACCESS Newswire
News headline image
Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy
Via ACCESS Newswire
News headline image
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives
Via ACCESS Newswire
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs
Via ACCESS Newswire
News headline image
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
From Renovaro Inc
Via GlobeNewswire

Frequently Asked Questions

Is Lunai Bioworks Inc. - Common Stock publicly traded?
Yes, Lunai Bioworks Inc. - Common Stock is publicly traded.
What exchange does Lunai Bioworks Inc. - Common Stock trade on?
Lunai Bioworks Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lunai Bioworks Inc. - Common Stock?
The ticker symbol for Lunai Bioworks Inc. - Common Stock is RENB on the Nasdaq Stock Market
What is the current price of Lunai Bioworks Inc. - Common Stock?
The current price of Lunai Bioworks Inc. - Common Stock is 1.420
When was Lunai Bioworks Inc. - Common Stock last traded?
The last trade of Lunai Bioworks Inc. - Common Stock was at 09/30/25 04:00 PM ET
What is the market capitalization of Lunai Bioworks Inc. - Common Stock?
The market capitalization of Lunai Bioworks Inc. - Common Stock is 34.35M
How many shares of Lunai Bioworks Inc. - Common Stock are outstanding?
Lunai Bioworks Inc. - Common Stock has 34M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story